Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N07 OTHER NERVOUS SYSTEM DRUGS
N07B DRUGS USED IN ADDICTIVE DISORDERS
N07BB Drugs used in alcohol dependence
N07BB05 Nalmefene
D10812 Nalmefene hydrochloride hydrate (JAN) <JP>
USP drug classification [BR:br08302]
Anti-Addiction/Substance Abuse Treatment Agents
Opioid Reversal Agents
Nalmefene
D10812 Nalmefene hydrochloride hydrate (JAN)
Therapeutic category of drugs in Japan [BR:br08301]
1 Agents affecting nervous system and sensory organs
11 Agents affecting central nervous system
119 Miscellaneous
1190 Miscellaneous
D10812 Nalmefene hydrochloride hydrate (JAN)
Drug groups [BR:br08330]
Analgesic
DG01586 Opioid receptor antagonist
DG00998 Nalmefene
D10812 Nalmefene hydrochloride hydrate
DG01587 Opioid receptor agonist/antagonist
DG00998 Nalmefene
D10812 Nalmefene hydrochloride hydrate
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Opioid
OPRM1
D10812 Nalmefene hydrochloride hydrate (JAN) <JP>
OPRK1
D10812 Nalmefene hydrochloride hydrate (JAN) <JP>
OPRD1
D10812 Nalmefene hydrochloride hydrate (JAN) <JP>
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D10812
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D10812
Drug groups [BR:br08330]
Analgesic
DG01586 Opioid receptor antagonist
DG00998 Nalmefene
DG01587 Opioid receptor agonist/antagonist
DG00998 Nalmefene